Search Results

All Content Formulary Only Other Content

Scottish Formulary has compiled the following search results: We have found 17 results when searching "Capecitabine"

DOCUMENT

02/02/2022 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 02 February 2022 Page 1 of 15 East Region Formulary Committee Minutes Date: 02 February 2022 Time: 2pm – 4pm Location: MS Teams Present: Jane Browning Lead P...

DOCUMENT

30/03/2022 East Region formulary Committee Minutes

East Region Formulary ERFC Minutes 02 February 2022 Page 1 of 12 East Region Formulary Committee Minutes Date: 30 March 2022 Time: 2pm – 4:48pm Location: MS Teams Present: Ruth Cameron Advanc...

FORMULARY DECISION

Capecitabine : Xeloda

193/05 : Following surgery for Stage III (Dukes C stage) colon cancer

FORMULARY DECISION

Capecitabine : Xeloda

401/07 : First line treatment of patients with advanced gastric cancer in combination with a platinum-based chemotherapy regimen

FORMULARY DECISION

Capecitabine : Xeloda

716/11 : In combination with oxaliplatin for the adjuvant treatment of patients following surgery of stage III (Dukes' stage C) colon cancer.

FORMULARY DECISION

Capecitabine : Xeloda

Treatment of early breast cancer following neoadjuvant anthracycline and/or taxane based chemotherapy with residual disease in breast or axillary lymph nodes at time of surgery.

FORMULARY DECISION

Capecitabine : Xeloda

Adjuvant use following potentially curative surgery for adenocarcinoma of the pancreas to replace 5FU/folinic acid given according to the Mayo schedule